logo

For the Inventor, By the Inventor

Shizuoka, Japan

Katsuichi Shuto

This inventor holds 19 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kogyo Kabushiki Kaisha. Active years: 1979-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuichi Shuto. Retrieved from https://idiyas.com/inventor/katsuichi-shuto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19

% Patents Active = 100.0


Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 164(Granted Patents)


Location History:

  • Shizuoka, JP (1979 - 1992)
  • Ube, JP (1994)
  • Mishima, JP (1989 - 1995)

Company Filing History:

goldMedal17 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
silverMedal2 out of 45 
 
Kyowa Hakko Kogyo Kabushiki Kaisha
 patents

Years Active: 1979-1995

Loading Chart...
Loading Chart...
Areas of Expertise:
Triphenylmethane Derivatives
Quinoline Derivative
s-Triazolo(3,4-I)Purine Derivatives
Dibenz[b,e]Oxepin Derivatives
Furan Derivatives
Rectal Motilin Preparation
Anti-Dementia Agent
Phosphorus-Containing Peptide Derivatives
Antiulcer Compositions
Physiologically Active Substances
Convulsion Treatment
Gastro-Intestinal Disorders
19 patents (USPTO):Explore Patents
1. 5413997 - Triphenylmethane derivatives (1995-05-09),
2. 5319085 - Quinoline derivative having serotonin-3 receptor antagonizing activity (1994-06-07),
3. 5173492 - s-Triazolo(3,4-I)purine derivatives (1992-12-22),
4. 5116863 - Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof (1992-05-26),
5. 5112867 - Triphenylmethane derivatives (1992-05-12),
6. 5075301 - Furan derivatives useful for the treatment of gastro-intestinal disorders (1991-12-24),
7. 5011824 - Rectal motilin preparation (1991-04-30),
8. 4952576 - UCY1003 derivatives (1990-08-28),
9. 4914198 - Novel substance UCY1003 and process for preparing the same (1990-04-03),
10. 4851414 - Anti-dementia agent (1989-07-25),
11. 4683220 - Novel physiologically active substances K-26, a process for preparation (1987-07-28),
12. 4677125 - Phosphorus-containing peptide derivatives (1987-06-30),
13. 4657916 - Quinoline-N-oxide derivative and pharmaceutical composition (1987-04-14),
14. 4618613 - Preventive and healing composition for diseases due to lipoxygenase (1986-10-21),
15. 4596804 - Dibenz[b,e]oxepin compounds (1986-06-24),

Title: The Innovative Contributions of Katsuichi Shuto

Introduction: Katsuichi Shuto, based in Shizuoka, Japan, is a prominent inventor known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio comprising 19 patents, Shuto has focused on innovations that address critical health issues, particularly in the treatment of osteoporosis.

Latest Patents: Among his latest inventions, Shuto has developed triphenylmethane derivatives that exhibit bone absorption inhibiting effects. These derivatives hold promising potential as medicaments for treating osteoporosis, marking a notable advancement in pharmaceutical innovation. Another significant invention is a quinoline derivative that demonstrates serotonin-3 receptor antagonizing activity, further showcasing his expertise in creating therapeutic agents.

Career Highlights: Throughout his career, Katsuichi Shuto has been associated with reputable companies in the pharmaceutical sector, notably Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki Kaisha. His work has advanced both the scientific understanding and practical applications of pharmaceutical compounds, contributing to improved patient outcomes.

Collaborations: Shuto has collaborated with esteemed colleagues, including Shunji Ichikawa and Hiroshi Kase. These partnerships have fostered a rich environment for innovation, enhancing the quality and scope of research and development within their fields.

Conclusion: Katsuichi Shuto's contributions to the field of medicinal chemistry through his innovative patents exemplify the vital role of inventors in healthcare advancement. His work continues to inspire future research and development, paving the way for novel treatments that can significantly impact patients' lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…